Many types of exosomes derived by cancer cells may present the Fas ligand (FasL), whose activation is not only known from the literature to silence the immune response by inducing apoptosis of activated CD8+ T cells, but is also correlated with poor prognosis [85]. The gene discussed is CD8A; the disease is cancer.